Drugs / TIV
last change Dec 2001 re-read 2 minutes ago

TIV

Vaccine

Developed for
influenza

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00192309 Comparator Sep → Dec 2001 influenza MedImmune LLC Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT00192309
Modality Vaccine “Trivalent inactivated vaccine (TIV)” NCT00192309